中国医药 (600056.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(中国医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 8,171,796,241.969,094,308,027.3612,530,663,199.1810,675,419,517.219,265,776,180.649,131,551,949.158,519,901,885.91
 营业收入(元) 8,171,796,241.969,094,308,027.3612,530,663,199.1810,675,419,517.219,265,776,180.649,131,551,949.158,519,901,885.91
二、营业总成本(元) 7,964,149,431.538,627,133,869.2412,093,668,632.7910,347,284,940.219,028,090,744.188,591,075,474.608,171,489,314.14
 营业成本(元) 7,274,783,779.047,923,626,831.6211,297,491,990.299,370,284,351.038,203,558,457.877,868,167,393.307,403,775,673.04
 研发费用(元) 19,805,298.3526,494,155.3827,176,715.8528,339,132.5516,635,299.7017,657,578.3714,696,949.23
 营业税金及附加(元) 28,105,443.1135,153,235.8232,380,793.2029,299,786.1026,270,581.6830,139,295.6529,587,568.90
 销售费用(元) 341,824,810.83404,837,543.62463,351,369.54572,877,656.73483,035,901.81426,816,014.71467,781,977.35
 管理费用(元) 256,249,344.16256,414,886.36230,026,259.55329,831,969.43239,721,255.60220,510,299.50220,636,621.82
 财务费用(元) 43,380,756.04-19,392,783.5643,241,504.3616,652,044.3758,869,247.5227,784,893.0735,010,523.80
  其中:利息费用(元) 40,975,639.6431,471,674.7742,736,450.7891,395,741.2233,842,138.4348,362,653.2443,980,322.73
  其中:利息收入(元) 19,340,152.269,661,361.3913,293,704.466,061,301.5412,297,853.239,339,953.047,525,910.54
 资产减值损失(元) 6,077,171.03-1,579,082.95-69,833.43-279,552,905.19-103,951.01-980,225.59-22,906.30
 信用减值损失(元) 4,393,863.67-35,960,217.56-54,319,761.62-89,787,390.7214,604,689.52-15,680,413.73541,086.91
三、其他经营收益
 加:公允价值变动收益(元) 301,540.68-795,084.84827,810.112,278,061.65-414.92--
 加:投资收益(元) -3,589,279.9916,104,698.3915,302,950.13405,145.9212,694,575.3337,948,873.51-47,643.81
  其中:对联营企业和合营企业的投资收益(元) 7,965,000.0036,875,036.5520,873,700.001,642,163.5038,104,983.0547,000,000.006,471,900.00
 资产处置收益(元) -1,599.36-164,592.522,832,053.23550,246.50-96,018.85-3,043.1515,897,528.31
 其他收益(元) 17,517,505.6421,518,071.395,277,123.158,919,809.053,086,584.1217,483,697.6417,208,894.79
四、营业利润(元) 232,346,012.10466,297,950.03406,844,907.96-29,052,455.79267,870,900.65578,890,006.69381,989,531.67
 加:营业外收入(元) 7,239,587.267,245,208.42211,653.19-623,548.315,690,060.082,839,829.247,004,453.99
 减:营业外支出(元) 4,735,727.165,852,871.24446,211.899,452,994.73393,189.338,204,220.01431,332.98
五、利润总额(元) 234,849,872.20467,690,287.21406,610,349.26-39,128,998.83273,167,771.40573,525,615.92388,562,652.68
 减:所得税费用(元) 127,940,419.56111,519,299.4086,028,006.9310,958,699.2466,795,393.85142,680,803.5087,723,946.14
六、净利润(元) 106,909,452.64356,170,987.81320,582,342.33-50,087,698.07206,372,377.55430,844,812.42300,838,706.54
(一)按经营持续性分类
  持续经营净利润(元) 106,909,452.64356,170,987.81320,582,342.33-50,087,698.07206,372,377.55430,844,812.42300,838,706.54
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 50,562,902.52274,777,537.50268,770,140.93-31,008,492.07150,693,947.82370,039,677.75245,980,075.89
  少数股东损益(元) 56,346,550.1281,393,450.3151,812,201.40-19,079,206.0055,678,429.7360,805,134.6754,858,630.65
 扣除非经常性损益后的净利润(元) 39,425,223.63264,328,532.40252,398,608.34-117,014,689.66150,660,954.51350,041,377.40216,078,999.08
七、每股收益
 一、基本每股收益(元) 0.030.180.18-0.020.100.180.23
 二、稀释每股收益(元) 0.030.180.18-0.020.100.180.23
八、其他综合收益(元) -912,648.981,393,748.44225,522.188,757,205.78119,481.65--
 归属于母公司股东的其他综合收益(元) -912,648.981,393,748.44225,522.189,197,412.00119,481.65--
九、综合收益总额(元) 105,996,803.66357,564,736.25320,807,864.51-41,330,492.29206,491,859.20430,027,313.19300,838,706.54
 归属于母公司所有者的综合收益总额(元) 49,650,253.54276,171,285.94268,995,663.11-21,811,080.07150,813,429.47369,222,178.52245,980,075.89
 归属于少数股东的综合收益总额(元) 56,346,550.1281,393,450.3151,812,201.40-19,519,412.2255,678,429.7360,805,134.6754,858,630.65
公告日期 2023-10-282023-08-252023-04-292023-04-292022-10-292022-08-272022-04-30
审计意见(境内) 标准无保留意见

前瞻产业研究院